First New Endometriosis Drug Approval in 10 Years Offers Hope, But With Some Caveats

In: Topics in Pain Management · 2019 · vol. 34(11) , pp. 8–9 · doi:10.1097/01.tpm.0000559756.82728.f7 · W4245809427
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-08, 2026-08-01 ⓘ

The FDA approved the first new endometriosis drug in a decade, providing a new treatment option but with recognized limitations.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK